Wellington-based, ASX-listed heath technology firm Volpara has bought CRA Health, a US leader in breast cancer risk assessment, for US$18 million ($25m).A further US$4m is payable upon CRA meeting of key performance and staff-retention…
Source: NZ Herald Business News